Received Apr 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 4T93R | — |
Patient reported prior to receiving the vaccine that she has fainted before/during vaccines. Vaccine was administered around 11:10am. After the vaccine was administered, within a minute (11:12am) she started to faint/appeared to almost be seizing rather than a full dead-weight drop (tensed up in the arms of the pharmacist/technican attending to her). The patient was shaken in an attempt to wake her, however, she was not responsive. When she came to she stated she was "okay" but continued to fade in and out. She was laid on the floor as to follow vaccine training until paramedics arrived. Paramedics arrived by 11: 25am and checked her vitals. They found her blood pressure was low (unknown specific value) and took her on the stretcher to ensure that she would get the proper approval that she is okay. Further reactions unknown.
asthma